AISAP Cardio vs Bunkerhill ECG-EF

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AISAP Cardio

by AISAP

Bunkerhill ECG-EF

by Bunkerhill Health

AI Verdict

AISAP Cardio provides comprehensive cardiac diagnostic assessments and measurements from point-of-care ultrasound, offering a broad view of cardiac health including LVEF and valvular pathologies. In contrast, Bunkerhill ECG-EF specifically leverages routine 12-lead ECGs to detect reduced LVEF, serving as a rapid, non-invasive screening tool for heart failure risk. While both aid in identifying patients at risk for heart failure by assessing LVEF, they utilize distinct diagnostic modalities and offer different scopes of cardiac evaluation.

Choose AISAP Cardio if…

Choose AISAP Cardio if your clinical setting requires immediate, comprehensive cardiac diagnostic assessments and measurements directly at the point of care. This tool is ideal for clinicians needing real-time AI-powered interpretation of ultrasound images to detect structural heart disease, valvular pathologies, and heart failure at the bedside, integrating seamlessly with existing POCUS workflows.

View AISAP Cardio →

Choose Bunkerhill ECG-EF if…

Choose Bunkerhill ECG-EF if your primary goal is to efficiently screen a broad patient population for reduced left ventricular ejection fraction using readily available routine 12-lead ECG data. This software-only solution is best suited for integrating with EHRs to automate the early identification of patients at risk for heart failure without requiring additional imaging equipment or specialized ultrasound expertise.

View Bunkerhill ECG-EF →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	AISAP Cardio	Bunkerhill ECG-EF
Pricing	Unknown	Contact sales for pricing details.
Deployment	Cloud-based	Cloud-native platform (Carebricks) that integrates with existing health system infrastructure like EHRs.
FDA Status	1 AI-estimated	Yes AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

AISAP Cardio

AISAP Cardio excels in usability by empowering non-specialists with real-time guidance for image acquisition and interpretation directly at the patient's bedside, making advanced diagnostics more accessible. This direct, interactive approach with real-time feedback for image quality offers a more hands-on and empowering user experience compared to Bunkerhill ECG-EF's automated processing of existing ECG data.

Clinical Value

AISAP Cardio

AISAP Cardio provides a more comprehensive diagnostic assessment at the point of care, covering multiple valvular pathologies, Left Ventricle Ejection Fraction (LVEF), and ventricular dimensions with high sensitivity and specificity. It has been clinically validated to enable non-cardiologists to interpret echocardiograms as accurately as expert cardiologists for a wide range of structural heart diseases. While Bunkerhill ECG-EF offers valuable early identification of reduced LVEF from routine ECGs, its clinical scope is more focused on a single screening parameter.

Pricing & Value

Bunkerhill ECG-EF

Both tools require direct contact for pricing, making a direct cost comparison difficult. However, Bunkerhill ECG-EF's unique business model allows research institutions contributing data to leverage its solutions for free in perpetuity, suggesting a potentially higher long-term value proposition for those partners. AISAP Cardio, while aiming for cost savings and utilizing inexpensive POCUS devices, does not publicly offer a similar 'free in perpetuity' model.

Enterprise Readiness

Bunkerhill ECG-EF

Both tools demonstrate strong enterprise readiness with cloud-based deployments, EHR/EMR/PACS integration, and FDA clearance. However, Bunkerhill ECG-EF explicitly states 'Yes' for both HIPAA compliance and Business Associate Agreement (BAA) in its structured facts, and its Carebricks platform is noted for enabling tailored, AI-powered workflows and being used by major health systems. AISAP Cardio also states HIPAA compliance in search results, but the explicit 'Yes' in the structured data for Bunkerhill gives it a slight edge in transparency and confirmed readiness.

Innovation

Bunkerhill ECG-EF

Both tools are innovative in applying AI to cardiology. AISAP Cardio is a pioneer in bringing comprehensive, AI-powered diagnostic assessment to point-of-care ultrasound, enabling non-specialists to perform expert-level cardiac diagnoses with real-time guidance. However, Bunkerhill ECG-EF's broader 'Generative AI for clinical reasoning and action' platform, Carebricks, suggests a more advanced and comprehensive AI approach to patient data analysis and automated workflows, giving it a slight edge in the breadth of its innovative approach.

Support & Docs

Tie

Neither the provided structured facts nor the public web search results offer explicit details regarding customer support channels, service level agreements, or comprehensive documentation for either AISAP Cardio or Bunkerhill ECG-EF. While AISAP Cardio mentions 'education tools' as part of its platform, this is not a direct indicator of dedicated customer support or extensive documentation. Therefore, based on the available information, it is not possible to distinguish between the two.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	AISAP Cardio	Bunkerhill ECG-EF
Name	AISAP Cardio	Bunkerhill ECG-EF
Company	Aisap	BunkerHill Health
Description	FDA-cleared, AI-powered point-of-care ultrasound (POCUS) software platform that provides rapid, comprehensive cardiac diagnostic assessments and measurements, enabling early detection of structural heart disease and heart failure at the bedside.	FDA-cleared artificial intelligence algorithm that detects reduced left ventricular ejection fraction (LVEF u2264 40%) from routine 12-lead electrocardiograms (ECGs), aiding in the early identification of patients at risk for heart failure.
Key Functionality	AI-powered interpretation for early cardiac disease detection, comprehensive cardiac ultrasound software package, automated generation of analyses, interpretations, and reports, assessment of valvular pathologies, measurement of LVEF, ventricular dimensions, atrial areas, ascending aorta diameter, and IVC diameter.	AI algorithm to detect reduced Left Ventricular Ejection Fraction (LVEF u2264 40%) from routine 12-lead ECG data.
Data Input	Point-of-care ultrasound (POCUS)	Routine 12-lead electrocardiograms (ECGs)

Videos

Demos, reviews, and walkthroughs featuring AISAP Cardio and Bunkerhill ECG-EF.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What type of patient data or diagnostic modality does each tool utilize for its analysis?

AISAP Cardio is an AI-powered point-of-care ultrasound (POCUS) software platform that provides rapid, comprehensive cardiac diagnostic assessments and measurements. Bunkerhill ECG-EF is an artificial intelligence algorithm that detects reduced left ventricular ejection fraction (LVEF u2264 40%) from routine 12-lead electrocardiograms (ECGs).

What specific cardiac conditions or measurements can each tool provide?

AISAP Cardio offers comprehensive cardiac ultrasound software, including AI-powered interpretation for early cardiac disease detection, assessment of valvular pathologies (mitral, tricuspid, aortic regurgitation, aortic stenosis), and measurement of LVEF, ventricular dimensions, atrial areas, ascending aorta diameter, and IVC diameter. Bunkerhill ECG-EF specifically analyzes routine 12-lead ECG data to detect reduced Left Ventricular Ejection Fraction (LVEF u2264 40%), aiding in the early identification of patients at risk for heart failure.

How do these tools integrate with existing clinical workflows and electronic health records?

AISAP Cardio is a cloud-based SaaS platform designed for integration with existing clinical workflows, EHR/EMR, and PACS. Bunkerhill ECG-EF integrates seamlessly with Electronic Medical Records (EMR) or ECG Management Systems (EMS).

What is the primary clinical utility or benefit each tool offers for patient care?

AISAP Cardio enables early detection of structural heart disease and heart failure at the bedside through rapid, comprehensive cardiac diagnostic assessments and measurements. Bunkerhill ECG-EF aids in the early identification of patients at risk for heart failure by detecting reduced LVEF from routine ECGs, serving as a non-invasive, rapid, and accessible cardiac diagnostic tool.